MiR-191-5p alleviates microglial cell injury by targeting Map3k12 (mitogen-activated protein kinase kinase kinase 12) to inhibit the MAPK (mitogen-activated protein kinase) signaling pathway in Alzheimer’s disease

References

• Barone E. Brain insulin resistance: an early risk factor for Alzheimer’s disease development in Down syndrome. Neural Regen Res. 2022 Feb;17(2):333–335.
   PubMed Web of Science ®Google Scholar
• Realdon O, Rossetto F, Nalin M, et al. Technology-enhanced multi-domain at home continuum of care program with respect to usual care for people with cognitive impairment: the Ability-TelerehABILITation study protocol for a randomized controlled trial. BMC Psychiatry. 2016 Nov25;16(1):425.
   PubMedGoogle Scholar
• Zhang H, Elefant F. Exploring the Alzheimer’s disease neuroepigenome: recent advances and future trends. Neural Regen Res. 2022 Feb;17(2):325–327.
   PubMed Web of Science ®Google Scholar
• Tang L, Xiang Q, Xiang J, et al. Tripterygium glycoside ameliorates neuroinflammation in a mouse model of Aβ25-35-induced Alzheimer’s disease by inhibiting the phosphorylation of IκBα and p38. Bioengineered. 2021 Dec;12(1):8540–8554.
   PubMed Web of Science ®Google Scholar
• Ruan Z. Extracellular vesicles drive tau spreading in Alzheimer’s disease. Neural Regen Res. 2022 Feb;17(2):328–329.
   PubMed Web of Science ®Google Scholar
• Wen MM, Ismail NIK, Nasra MMA, et al. Repurposing ibuprofen-loaded microemulsion for the management of Alzheimer’s disease: evidence of potential intranasal brain targeting. Drug Deliv. 2021 Dec;28(1):1188–1203.
   PubMed Web of Science ®Google Scholar
• Wu X, Cai H, Pan L, et al. Small molecule natural products and Alzheimer’s Disease. Curr Top Med Chem. 2019;19(3):187–204.
   PubMed Web of Science ®Google Scholar
• Ho L, Fivecoat H, Wang J, et al. Alzheimer’s disease biomarker discovery in symptomatic and asymptomatic patients: experimental approaches and future clinical applications. Exp Gerontol. 2010 Jan;45(1):15–22.
   PubMed Web of Science ®Google Scholar
• Knierim JJ. The hippocampus. Curr Biol. 2015 Dec 7;25(23):R1116–R1121.
   PubMed Web of Science ®Google Scholar
• Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer’s disease. J Cell Biol. 2018 Feb 5;217(2):459–472.
   PubMed Web of Science ®Google Scholar
• Koelsch G. BACE1 function and inhibition: implications of intervention in the amyloid pathway of Alzheimer’s disease pathology. Molecules. 2017 Oct 13;22(10):1723.
   PubMed Web of Science ®Google Scholar
• Miyawaki K, Nakayama H, Matsuno S, et al. Three-dimensional and fractal analyses of assemblies of amyloid beta protein subtypes [Abeta40 and Abeta42(43)] in canine senile plaques. Acta Neuropathol. 2002 Mar;103(3):228–236.
   PubMed Web of Science ®Google Scholar
• Cai Z, Hussain MD, Yan LJ. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease. Int J Neurosci. 2014 May;124(5):307–321.
   PubMed Web of Science ®Google Scholar
• Spangenberg EE, Green KN. Inflammation in Alzheimer’s disease: lessons learned from microglia-depletion models. Brain Behav Immun. 2017 Mar;61:1–11.
   PubMed Web of Science ®Google Scholar
• Šimić G, Babić Leko M, Wray S, et al. Tau protein hyperphosphorylation and aggregation in Alzheimer’s Disease and other tauopathies, and possible neuroprotective strategies. Biomolecules. 2016 Jan 6;6(1):6.
   PubMed Web of Science ®Google Scholar
• Jouanne M, Rault S, Voisin-Chiret AS. Tau protein aggregation in Alzheimer’s disease: an attractive target for the development of novel therapeutic agents. Eur J Med Chem. 2017 Oct 20;139:153–167.
   PubMed Web of Science ®Google Scholar
• Huang Y. The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases. J Cell Mol Med. 2018 Dec;22(12):5768–5775.
   PubMed Web of Science ®Google Scholar
• Li J, Li D, Zhou H, et al. MicroRNA-338-5p alleviates neuronal apoptosis via directly targeting BCL2L11 in APP/PS1 mice. Aging (Albany NY). 2020 Oct 21;12(20):20728–20742.
   PubMedGoogle Scholar
• Shi Z, Zhang K, Zhou H, et al. Increased miR-34c mediates synaptic deficits by targeting synaptotagmin 1 through ROS-JNK-p53 pathway in Alzheimer’s Disease. Aging Cell. 2020 Mar;19(3):e13125.
   PubMed Web of Science ®Google Scholar
• Wang X, Liu D, Huang HZ, et al. A novel MicroRNA-124/PTPN1 signal pathway mediates synaptic and memory deficits in Alzheimer’s disease. Biol Psychiatry. 2018 Mar 1;83(5):395–405.
   PubMed Web of Science ®Google Scholar
• Sánchez-Mora C, Soler Artigas M, Garcia-Martínez I, et al. Epigenetic signature for attention-deficit/hyperactivity disorder: identification of miR-26b-5p, miR-185-5p, and miR-191-5p as potential biomarkers in peripheral blood mononuclear cells. Neuropsychopharmacology. 2019 Apr;44(5):890–897.
   PubMed Web of Science ®Google Scholar
• Vistbakka J, Sumelahti ML, Lehtimäki T, et al. Evaluation of serum miR-191-5p, miR-24-3p, miR-128-3p, and miR-376c-3 in multiple sclerosis patients. Acta Neurol Scand. 2018 Aug;138(2):130–136.
   PubMed Web of Science ®Google Scholar
• Chen J, Qi Y, Liu CF, et al. MicroRNA expression data analysis to identify key miRNAs associated with Alzheimer’s disease. J Gene Med. 2018 Jun;20(6):e3014.
   PubMed Web of Science ®Google Scholar
• Tan L, Yu JT, Tan MS, et al. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer’s disease. J Alzheimers Dis. 2014;40(4):1017–1027.
   PubMed Web of Science ®Google Scholar
• Bigeard J, Hirt H. Nuclear Signaling of Plant MAPKs. Front Plant Sci. 2018;9:469.
   PubMed Web of Science ®Google Scholar
• Yue J, López JM. Understanding MAPK signaling pathways in apoptosis. Int J Mol Sci. 2020 Mar 28;21(7):2346.
   PubMed Web of Science ®Google Scholar
• Luo X, Wei J, Yang FL, et al. Exosomal lncRNA HNF1A-AS1 affects cisplatin resistance in cervical cancer cells through regulating microRNA-34b/TUFT1 axis. Cancer Cell Int. 2019;19(1):323.
   PubMed Web of Science ®Google Scholar
• Perfettini JL, Castedo M, Nardacci R, et al. Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope. J Exp Med. 2005 Jan 17;201(2):279–289.
   PubMed Web of Science ®Google Scholar
• Schwenger P, Bellosta P, Vietor I, et al. Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):2869–2873.
   PubMed Web of Science ®Google Scholar
• Nakagami H, Morishita R, Yamamoto K, et al. Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells. Diabetes. 2001 Jun;50(6):1472–1481.
   PubMed Web of Science ®Google Scholar
• Ko HR, Ahn SY, Chang YS, et al. Human UCB-MSCs treatment upon intraventricular hemorrhage contributes to attenuate hippocampal neuron loss and circuit damage through BDNF-CREB signaling. Stem Cell Res Ther. 2018 Nov21;9(1):326.
   PubMed Web of Science ®Google Scholar
• Deng Y, Zhang J, Sun X, et al. miR-132 improves the cognitive function of rats with Alzheimer’s disease by inhibiting the MAPK1 signal pathway. Exp Ther Med. 2020 Dec;20(6):159.
   PubMed Web of Science ®Google Scholar
• Gao S, Lin J, Wang T, et al. Qingxin kaiqiao fang ameliorates memory impairment and inhibits apoptosis in APP/PS1 double transgenic mice through the MAPK pathway. Drug Des Devel Ther. 2019;13:459–475.
   PubMed Web of Science ®Google Scholar
• Lepore F, D’Alessandro G, Antonangeli F, et al. CXCL16/CXCR6 axis drives microglia/macrophages phenotype in physiological conditions and plays a crucial role in glioma. Front Immunol. 2018;9:2750.
   PubMed Web of Science ®Google Scholar
• Li L, Wu XH, Zhao XJ, et al. Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling. J Neuroinflammation. 2020 Feb 17;17(1):61.
   PubMed Web of Science ®Google Scholar
• Dalby B, Cates S, Harris A, et al. Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods. 2004 Jun;33(2):95–103.
   PubMed Web of Science ®Google Scholar
• Bao Y, Zhu Y, He G, et al. Dexmedetomidine attenuates neuroinflammation In LPS-Stimulated BV2 microglia cells through upregulation of miR-340. Drug Des Devel Ther. 2019;13:3465–3475.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yu J, Wang X, et al. MicroRNA-345-5p regulates depression by targeting suppressor of cytokine signaling 1. Brain Behav. 2020 Sep;10(9):e01653.
   PubMed Web of Science ®Google Scholar
• Rio DC, Ares M Jr., Hannon GJ, et al. Purification of RNA using TRIzol (TRI reagent). Cold Spring Harb Protoc. 2010 June;2010(6): pdb.prot5439.
   Google Scholar
• Kim B. Western blot Techniques. Methods Mol Biol. 2017;1606:133–139.
   PubMedGoogle Scholar
• Clément T, Salone V, Rederstorff M. Dual luciferase gene reporter assays to study miRNA function. Methods Mol Biol. 2015;1296:187–198.
   PubMedGoogle Scholar
• Bezzaouha A, Bouamra A, Ammimer A, et al. Non-parametric tests on SPSS to compare two or more means on matched samples. Tunis Med. 2020 Dec;98(12):932–941.
   PubMedGoogle Scholar
• Oboudiyat C, Glazer H, Seifan A, et al. Alzheimer’s disease. Semin Neurol. 2013 Sep;33(4):313–329.
   PubMed Web of Science ®Google Scholar
• Reiss AB, Arain HA, Stecker MM, et al. Amyloid toxicity in Alzheimer’s disease. Rev Neurosci. 2018 Aug 28;29(6):613–627.
   PubMed Web of Science ®Google Scholar
• Ji Y, Wang D, Zhang B, et al. MiR-361-3p inhibits β-amyloid accumulation and attenuates cognitive deficits through targeting BACE1 in Alzheimer’s disease. J Integr Neurosci. 2019 Sep 30;18(3):285–291.
   PubMed Web of Science ®Google Scholar
• Vassar R, Bennett BD, Babu-Khan S, et al. Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999 Oct 22;286(5440):735–741.
   PubMed Web of Science ®Google Scholar
• Lok K, Zhao H, Shen H, et al. Characterization of the APP/PS1 mouse model of Alzheimer’s disease in senescence accelerated background. Neurosci Lett. 2013 Dec 17;557(Pt B):84–89.
   PubMedGoogle Scholar
• Sun J, Xu J, Ling Y, et al. Fecal microbiota transplantation alleviated Alzheimer’s disease-like pathogenesis in APP/PS1 transgenic mice. Transl Psychiatry. 2019 Aug 5;9(1):189.
   PubMed Web of Science ®Google Scholar
• Zhou J, Yu W, Zhang M, et al. Imbalance of Microglial TLR4/TREM2 in LPS-Treated APP/PS1 Transgenic mice: a potential link between Alzheimer’s disease and systemic inflammation. Neurochem Res. 2019 May;44(5):1138–1151.
   PubMed Web of Science ®Google Scholar
• Kwon Y, Shin J, Nam K, et al. Rhizolutin, a Novel 7/10/6-Tricyclic dilactone, dissociates misfolded protein aggregates and reduces apoptosis/inflammation associated with Alzheimer’s Disease. Angew Chem Int Ed Engl. 2020 Dec 14;59(51):22994–22998.
   PubMed Web of Science ®Google Scholar
• Ding L, Wang L, Li Z, et al. The positive feedback loop of RHPN1-AS1/miR-1299/ETS1 accelerates the deterioration of gastric cancer. Biomed Pharmacother. 2020 Apr;124:109848.
   PubMed Web of Science ®Google Scholar
• Ding Y, Zhang H, Liu Z, et al. Carnitine palmitoyltransferase 1 (CPT1) alleviates oxidative stress and apoptosis of hippocampal neuron in response to beta-Amyloid peptide fragment Aβ(25-35). Bioengineered. 2021 Dec;12(1):5440–5449.
   PubMed Web of Science ®Google Scholar
• Bian H, Bian W, Lin X, et al. RNA interference silencing of glycogen synthase kinase 3β inhibites tau phosphorylation in mice with alzheimer disease. Neurochem Res. 2016 Sep;41(9):2470–2480.
   PubMed Web of Science ®Google Scholar
• Liu WF, Yang FJ, Niu XH. [Research progress of sentinel lymph node biopsy and regional dissection in melanoma]. Zhonghua Zhong Liu Za Zhi. 2019 Jul 23;41(7):481–485.
   PubMedGoogle Scholar
• Sabry R, El Sharkawy RE, Gad NM. MiRNA −483-5p as a potential noninvasive biomarker for early detection of Alzheimer’s Disease. Egypt J Immunol. 2020 Jun;27(2):59–72.
   PubMedGoogle Scholar
• Kumar S, Reddy PH, New A. Discovery of MicroRNA-455-3p in Alzheimer’s Disease. J Alzheimers Dis. 2019;72(s1):S117–s130.
   PubMedGoogle Scholar
• Salta E, De Strooper B. microRNA-132: a key noncoding RNA operating in the cellular phase of Alzheimer’s disease. Faseb J. 2017 Feb;31(2):424–433.
   PubMed Web of Science ®Google Scholar
• Li H, Du M, Xu W, et al. MiR-191 downregulation protects against isoflurane-induced neurotoxicity through targeting BDNF. Toxicol Mech Methods. 2021 Jun;31(5):367–373.
   PubMed Web of Science ®Google Scholar
• van Spronsen M, van Battum EY, Kuijpers M, et al. Developmental and activity-dependent miRNA expression profiling in primary hippocampal neuron cultures. PLoS One. 2013;8(10):e74907.
   PubMed Web of Science ®Google Scholar
• Mellios N, Huang HS, Grigorenko A, et al. A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex. Hum Mol Genet. 2008 Oct 1;17(19):3030–3042.
   PubMed Web of Science ®Google Scholar
• Hong H, Li Y, Su B. Identification of Circulating miR-125b as a potential biomarker of Alzheimer’s Disease in APP/PS1 Transgenic Mouse. J Alzheimers Dis. 2017;59(4):1449–1458.
   PubMed Web of Science ®Google Scholar
• Siu M, Sengupta Ghosh A, Lewcock JW. Dual leucine zipper kinase inhibitors for the treatment of neurodegeneration. J Med Chem. 2018 Sep 27;61(18):8078–8087.
   PubMed Web of Science ®Google Scholar
• Mata M, Merritt SE, Fan G, et al. Characterization of dual leucine zipper-bearing kinase, a mixed lineage kinase present in synaptic terminals whose phosphorylation state is regulated by membrane depolarization via calcineurin. J Biol Chem. 1996 Jul 12;271(28):16888–16896.
   PubMed Web of Science ®Google Scholar
• Le Pichon CE, Meilandt WJ, Dominguez S, et al. Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease. Sci Transl Med. 2017 Aug 16;9(403):eaag0394.
   PubMed Web of Science ®Google Scholar
• Daviau A, Couture JP, Blouin R. Loss of DLK expression in WI-38 human diploid fibroblasts induces a senescent-like proliferation arrest. Biochem Biophys Res Commun. 2011 Sep 23;413(2):282–287.
   PubMed Web of Science ®Google Scholar
• Yang CY, Wang J, Zhang JQ, et al. Human circular RNA hsa_circRNA_101705 (circTXNDC11) regulates renal cancer progression by regulating MAPK/ERK pathway. Bioengineered. 2021 Dec;12(1):4432–4441.
   PubMed Web of Science ®Google Scholar
• Xu Y, Sun Q, Yuan F, et al. RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting the p38 MAPK signalling pathway. J Exp Clin Cancer Res. 2020 Aug 31;39(1):174.
   PubMed Web of Science ®Google Scholar
• Wang L, Sun L, Liu R, et al. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression. J Exp Clin Cancer Res. 2021 Feb 17;40(1):72.
   PubMed Web of Science ®Google Scholar
• Wang C, Yu JT, Miao D, et al. Targeting the mTOR signaling network for Alzheimer’s disease therapy. Mol Neurobiol. 2014 Feb;49(1):120–135.
   PubMed Web of Science ®Google Scholar
• Jia L, Piña-Crespo J, Li Y. Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease. Mol Brain. 2019 Dec 4;12(1):104.
   PubMed Web of Science ®Google Scholar